Using immunohistochemical (IHC) staining, Borcherding et al. reported strong WNT5A expression in normal mammary ducts and acini, but reduced WNT5A expression was observed in 75 % of triple negative breast cancers (TNBC), an aggressive breast cancer subtype [12]. The gene discussed is WNT5A; the disease is breast carcinoma.